Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 178150
Corporate User License Price USD 7500
Corporate User License Price INR 534450
Site License Price USD 5000
Site License Price INR 356300
Request a Quote

Report Title

Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018

Quote Request for License Type
License Type Price  
Single User License USD 2500
Site License USD 5000
Enterprise Wide License USD 7500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Thoracic Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2018



Executive Summary

Thoracic Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Thoracic Aortic Stent Grafts-Medical Devices Pipeline Assessment, 2018" provides an overview of Thoracic Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Thoracic Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Thoracic Aortic Stent Grafts under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Thoracic Aortic Stent Grafts and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Thoracic Aortic Stent Grafts under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Thoracic Aortic Stent Grafts Overview 6

3 Products under Development 7

3.1 Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 7

3.2 Thoracic Aortic Stent Grafts-Pipeline Products by Territory 8

3.3 Thoracic Aortic Stent Grafts-Pipeline Products by Regulatory Path 9

3.4 Thoracic Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 10

3.5 Thoracic Aortic Stent Grafts-Ongoing Clinical Trials 11

4 Thoracic Aortic Stent Grafts-Pipeline Products under Development by Companies 12

4.1 Thoracic Aortic Stent Grafts Companies-Pipeline Products by Stage of Development 12

4.2 Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 13

5 Thoracic Aortic Stent Grafts Companies and Product Overview 14

5.1 EndoSpan Ltd Company Overview 14

5.1.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Evasc Medical Systems Corp Company Overview 17

5.2.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Lombard Medical Technologies Inc. Company Overview 18

5.3.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Medtronic plc Company Overview 19

5.4.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 MicroPort Scientific Corp Company Overview 25

5.5.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 29

5.6.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 St. Jude Medical LLC Company Overview 30

5.7.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 Terumo Aortic Company Overview 31

5.8.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 TriVascular Inc Company Overview 42

5.9.1 TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.10 W. L. Gore & Associates Inc Company Overview 43

5.10.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 43

6 Thoracic Aortic Stent Grafts- Recent Developments 47

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 47

6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 49

6.3 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 49

6.4 Apr 27, 2018: Lifetech Scientific: To see how the Jianjian products with the second-largest share in the Asia-Pacific share the best in Europe 50

6.5 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 51

6.6 Apr 25, 2018: LeMaitre Q1 2018 Sales USD 26.0mm (+8%), EPS USD 0.19 (+17%) 52

6.7 Apr 24, 2018: Terumo Aortic Announces European Launch of RelayPro Thoracic Stent Graft System at Charing Cross 2018 53

6.8 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 53

6.9 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 54

6.10 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 54

6.11 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 56

6.12 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance 57

6.13 Feb 21, 2018: LeMaitre Reports Net Income Of USD 4.3mm In Q4 2017 58

6.14 Feb 20, 2018: VitalHub Selected to Showcase WellLinc Solution Among 40,000 International Attendees at HIMSS 2018 58

6.15 Feb 12, 2018: 33m investment in Scottish medical device factory 59

6.16 Feb 10, 2018: Vascutek surpassed 3,000 successful commercial implants 60

6.17 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 61

6.18 Jan 08, 2018: MicroPort Endovascular Attends CEC 2017 61

6.19 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region 63

6.20 Dec 15, 2017: Northwestern Memorial Hospital Surgeon First in Illinois to Repair Damaged Aorta with "Frozen Elephant Trunk" Graft 64

6.21 Nov 24, 2017: MicroPort Endovascular Hosts Product Launch of Castor 65

6.22 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 66

6.23 Nov 13, 2017: Medtronic to Present New Clinical Data on Vascular Interventions and Key Symposia at VEITHsymposium 2017 69

6.24 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 71

6.25 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 72

6.26 Oct 26, 2017: Talos Thoracic Stent Graft System Gains CFDA Green-Path 72

6.27 Oct 26, 2017: LeMaitre Q3 2017 Sales USD 24.8mm (+7%), Record EPS USD 0.25 (+49%) 73

6.28 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 73

6.29 Oct 10, 2017: First Post-market Implantation of Castor Successfully Completed 75

6.30 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 76

6.31 Oct 03, 2017: Bolton Medical Announces the First Implant of the RelayPro Clinical Trial for Treatment of Thoracic Aortic Dissections 77

6.32 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY 78

6.33 Aug 24, 2017: Cook Medical issues recall correction of Zenith Alpha Thoracic Endovascular Graft and removes specific sizes from the market 79

6.34 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 80

6.35 Aug 16, 2017: Zenith Alpha Thoracic Endovascular Graft by Cook Medical: Class I Recall-Potential Formation of Thrombus Inside Device 82

6.36 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261% 83

6.37 Jul 27, 2017: LeMaitre Q2 2017 Record Sales USD 25.8 mm (+15%), Record EPS USD 0.23 (+69%) 83

6.38 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 84

6.39 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 85

6.40 Jul 14, 2017: Kawasumi Laboratories Receives CE Mark Approval for Najuta Thoracic Stent System 86

6.41 Jul 13, 2017: Gore Announces First-in-Human Use of GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR 86

6.42 Jul 11, 2017: Castor Gains CFDA Approval 87

6.43 Jul 11, 2017: MicroPort Endovascular Attends SJVF-2017 87

6.44 Jul 11, 2017: MicroPort Endovascular Attends SJVF-2017 88

6.45 Jul 07, 2017: MPSC New COO Glendy Wang on Board 89

7 Appendix 90

7.1 Methodology 90

7.2 About GlobalData 93

7.3 Contact Us 93

7.4 Disclaimer 93

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

1.2 List of Figures

Figure 1: Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 7

Figure 2: Thoracic Aortic Stent Grafts-Pipeline Products by Territory 8

Figure 3: Thoracic Aortic Stent Grafts-Pipeline Products by Regulatory Path 9

Figure 4: Thoracic Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 10

Figure 5: Thoracic Aortic Stent Grafts-Ongoing Clinical Trials 11

1.1 List of Tables

Table 1: Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 7

Table 2: Thoracic Aortic Stent Grafts-Pipeline Products by Territory 8

Table 3: Thoracic Aortic Stent Grafts-Pipeline Products by Regulatory Path 9

Table 4: Thoracic Aortic Stent Grafts-Pipeline Products by Estimated Approval Date 10

Table 5: Thoracic Aortic Stent Grafts-Ongoing Clinical Trials 11

Table 6: Thoracic Aortic Stent Grafts Companies-Pipeline Products by Stage of Development 12

Table 7: Thoracic Aortic Stent Grafts-Pipeline Products by Stage of Development 13

Table 8: EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 14

Table 9: Nexus-Product Status 14

Table 10: Nexus-Product Description 14

Table 11: EndoSpan Ltd-Ongoing Clinical Trials Overview 15

Table 12: Nexus-A Multi-center Prospective Open-label Non-randomized Clinical Study to Evaluate the Safety and Performance of the Single Branch Nexus Aortic Arch Stent Graft System 16

Table 13: Nexus-Feasibility Clinical Study to Evaluate the Safety and Performance of the NEXUS Aortic Arch Stent Graft System 16

Table 14: Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 17

Table 15: TAS System-Product Status 17

Table 16: TAS System-Product Description 17

Table 17: Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 18

Table 18: TEVAR-Product Status 18

Table 19: TEVAR-Product Description 18

Table 20: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 21: Unitary Manifold Stent Graft System-Product Status 19

Table 22: Unitary Manifold Stent Graft System-Product Description 19

Table 23: Valiant Mona LSA System-Product Status 20

Table 24: Valiant Mona LSA System-Product Description 20

Table 25: Valiant Navion-Product Status 20

Table 26: Valiant Navion-Product Description 21

Table 27: Medtronic plc-Ongoing Clinical Trials Overview 22

Table 28: Valiant Mona LSA System-Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending Thoracic Aortic Aneurysms and Chronic Dissections 23

Table 29: Valiant Mona LSA System-Valiant Mona LSA Stent Graft System Early Feasibility Study 23

Table 30: Valiant Navion-Valiant Evo International Clinical Trial 24

Table 31: Valiant Navion-Valiant Evo US Clinical Trial 24

Table 32: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 25

Table 33: Fontus Branched Surgical Stent Graft System-Product Status 25

Table 34: Fontus Branched Surgical Stent Graft System-Product Description 25

Table 35: Talos Thoracic Stent-Graft System-Product Status 26

Table 36: Talos Thoracic Stent-Graft System-Product Description 26

Table 37: MicroPort Scientific Corp-Ongoing Clinical Trials Overview 27

Table 38: Talos Thoracic Stent-Graft System-Endovascular Aortic Repair for Aortic Dissection-XiJing Registry 28

Table 39: Talos Thoracic Stent-Graft System-Hybrid Operation in Thoracic Aortic Dissection-Registry of China 28

Table 40: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 29

Table 41: Aortic Stent Graft-Product Status 29

Table 42: Aortic Stent Graft-Product Description 29

Table 43: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 30

Table 44: Amplatzer TAA Vascular Graft-Product Status 30

Table 45: Amplatzer TAA Vascular Graft-Product Description 30

Table 46: Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 31

Table 47: Relay NBS Plus-Product Status 31

Table 48: Relay NBS Plus-Product Description 32

Table 49: Relay Thoracic Stent Graft With Plus Delivery System-Product Status 32

Table 50: Relay Thoracic Stent Graft With Plus Delivery System-Product Description 33

Table 51: RelayBranch Thoracic Stent-Graft System-Product Status 33

Table 52: RelayBranch Thoracic Stent-Graft System-Product Description 34

Table 53: RelayPro Thoracic Stent-Graft System-Acute Complicated Type B Thoracic Aortic Dissection-Product Status 34

Table 54: RelayPro Thoracic Stent-Graft System-Acute Complicated Type B Thoracic Aortic Dissection-Product Description 34

Table 55: RelayPro Thoracic Stent-Graft System-Blunt Traumatic Aortic Injury-Product Status 35

Table 56: RelayPro Thoracic Stent-Graft System-Blunt Traumatic Aortic Injury-Product Description 35

Table 57: RelayPro Thoracic Stent-Graft System-Descending Thoracic Aortic Aneurysms-Product Status 35

Table 58: RelayPro Thoracic Stent-Graft System-Descending Thoracic Aortic Aneurysms-Product Description 36

Table 59: Thoraflex Hybrid-Product Status 36

Table 60: Thoraflex Hybrid-Product Description 36

Table 61: Terumo Aortic-Ongoing Clinical Trials Overview 37

Table 62: Thoraflex Hybrid-Evaluation of the Thoraflex Hybrid Device for Use in the Repair or Replacement of the Ascending Aorta, Aortic Arch and Descending Aorta in an Open Surgical Procedure 38

Table 63: Thoraflex Hybrid-Thoraflex Hybrid Post-Market Study 38

Table 64: RelayPro Thoracic Stent-Graft System-Descending Thoracic Aortic Aneurysms-A Prospective, Multicenter, Non-blinded, Non-randomized Study of the Relay PRO Thoracic Stent-graft in Subjects with Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers 39

Table 65: RelayPro Thoracic Stent-Graft System-Descending Thoracic Aortic Aneurysms-A Prospective, Multicenter, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with Traumatic Injury of the Descending Thoracic Aorta 39

Table 66: RelayBranch Thoracic Stent-Graft System-A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery 40

Table 67: RelayPro Thoracic Stent-Graft System-Acute Complicated Type B Thoracic Aortic Dissection-A Prospective, Multicenter, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with an Acute, Complicated Type B Aortic Dissection 41

Table 68: TriVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Table 69: Ovation Thoracic Stent Graft System-Product Status 42

Table 70: Ovation Thoracic Stent Graft System-Product Description 42

Table 71: W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Table 72: GORE TAG Thoracic Branch Endoprosthesis-Product Status 43

Table 73: GORE TAG Thoracic Branch Endoprosthesis-Product Description 43

Table 74: W. L. Gore & Associates Inc-Ongoing Clinical Trials Overview 44

Table 75: GORE TAG Thoracic Branch Endoprosthesis-Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (Branched TAG Device) in the Treatment of Aortic Arch Aneurysms 45

Table 76: GORE TAG Thoracic Branch Endoprosthesis-Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta 45

Table 77: GORE TAG Thoracic Branch Endoprosthesis-Evaluation of the Gore Tag Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta 45

Table 78: GORE TAG Thoracic Branch Endoprosthesis-Evaluation of the GORE TAG Thoracic Branch Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms 46

Table 79: Glossary 92

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

EndoSpan Ltd

Evasc Medical Systems Corp

Lombard Medical Technologies Inc.

Medtronic plc

MicroPort Scientific Corp

Sree Chitra Tirunal Institute for Medical Sciences & Technology

St. Jude Medical LLC

Terumo Aortic

TriVascular Inc

W. L. Gore & Associates Inc

EndoSpan Ltd, Nexus; Evasc Medical Systems Corp, TAS System; Lombard Medical Technologies Inc., TEVAR; Medtronic plc, Unitary Manifold Stent Graft System; Medtronic plc, Valiant Mona LSA System; Medtronic plc, Valiant Navion; MicroPort Scientific Corp, Fontus Branched Surgical Stent Graft System; MicroPort Scientific Corp, Talos Thoracic Stent-Graft System; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Aortic Stent Graft; St. Jude Medical LLC, Amplatzer TAA Vascular Graft; Terumo Aortic, Relay NBS Plus; Terumo Aortic, Relay Thoracic Stent Graft With Plus Delivery System; Terumo Aortic, RelayBranch Thoracic Stent-Graft System; Terumo Aortic, RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection; Terumo Aortic, RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury; Terumo Aortic, RelayPro Thoracic Stent-Graft System - Descending Thoracic Aortic Aneurysms; Terumo Aortic, Thoraflex Hybrid; TriVascular Inc, Ovation Thoracic Stent Graft System; W. L. Gore &; Associates Inc, GORE TAG Thoracic Branch Endoprosthesis


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person